In conclusion, despite discrepancies due to the heterogeneity of the studied groups, our results and those involving other patient cohorts suggest that Gal-3 may be associated with clinical manifestations and pathological events relevant to development of SSc. The gene discussed is LGALS3; the disease is systemic sclerosis.